Prognostic factors in breast cancer
- PMID: 2657970
- DOI: 10.1002/ssu.2980050206
Prognostic factors in breast cancer
Abstract
There are several independent but interrelated prognostic factors predictive of recurrence and survival in breast cancer. These include axillary nodal status, histopathology, steroid receptors, proliferative rate, ploidy, and oncogene amplification. Axillary nodal status has been the traditional mainstay predictor for recurrence and survival in primary breast cancer. In addition, the presence of the estrogen and progesterone receptors has correlated with longer disease-free interval and overall survival in stage I and II breast cancer. Thymidine-labeling index and percent S-phase as measured by flow cytometry are indices of cell proliferation that correlate with relapse rate in pre- and postmenopausal women with breast cancer. Estrogen and progesterone receptor-negative tumors are more commonly aneuploid, and have higher percent S-phase, factors that predict for recurrence in Stage I breast cancer.
Similar articles
-
Steroid receptors and other prognostic factors in primary breast cancer.Semin Oncol. 1988 Apr;15(2 Suppl 1):20-5. Semin Oncol. 1988. PMID: 3285482 Review.
-
New biologic prognostic factors in breast cancer.Oncology (Williston Park). 1989 May;3(5):49-54; discussion 58, 61, 64. Oncology (Williston Park). 1989. PMID: 2578003 Review.
-
S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.Cancer. 1994 Oct 15;74(8):2287-99. doi: 10.1002/1097-0142(19941015)74:8<2287::aid-cncr2820740813>3.0.co;2-y. Cancer. 1994. PMID: 7922981
-
Prognostic factors in breast cancer.Hematol Oncol Clin North Am. 1989 Dec;3(4):641-52. Hematol Oncol Clin North Am. 1989. PMID: 2558104 Review.
-
[Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].Geburtshilfe Frauenheilkd. 1988 Oct;48(10):705-9. doi: 10.1055/s-2008-1026613. Geburtshilfe Frauenheilkd. 1988. PMID: 3234702 German.
Cited by
-
Diagnostic accuracy of metastatic axillary lymph nodes in breast MRI.Springerplus. 2016 Jun 16;5(1):735. doi: 10.1186/s40064-016-2419-7. eCollection 2016. Springerplus. 2016. PMID: 27376003 Free PMC article.
-
Expression of nuclear receptor co‑activator 7 protein is associated with poor prognosis of breast cancer.Oncol Lett. 2024 Apr 23;27(6):278. doi: 10.3892/ol.2024.14411. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38699661 Free PMC article.
-
Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?PLoS One. 2012;7(9):e45809. doi: 10.1371/journal.pone.0045809. Epub 2012 Sep 24. PLoS One. 2012. PMID: 23029254 Free PMC article.
-
St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study.Br J Surg. 2021 Dec 1;108(12):1465-1473. doi: 10.1093/bjs/znab327. Br J Surg. 2021. PMID: 34636842 Free PMC article.
-
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.Oncologist. 2022 Oct 1;27(10):822-831. doi: 10.1093/oncolo/oyac123. Oncologist. 2022. PMID: 35830543 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials